Network bioinformatics analysis provides insight into drug repurposing for COVID-19

Network bioinformatics analysis provides insight into drug repurposing for COVID-19

The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly ent...

Full description

Bibliographic Details
Main Authors: Xu Li, Jinchao Yu, Zhiming Zhang, Jing Ren, Alex E. Peluffo, Wen Zhang, Yujie Zhao, Jiawei Wu, Kaijing Yan, Daniel Cohen, Wenjia Wang
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Medicine in Drug Discovery
Subjects:
COVID-19
Network bioinformatics
Drug repurposing
SARS-CoV-2
Network pharmacology
Online Access:http://www.sciencedirect.com/science/article/pii/S2590098621000117

Internet

http://www.sciencedirect.com/science/article/pii/S2590098621000117

Similar Items